Approval · Notice of Compliance 21522 · 2018
SUROLAN: Notice of Compliance 21522
Issued November 13, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21522
- Date
- November 13, 2018
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- addition manufacturing and testing site - drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUROLAN | 00755753 | Marketed |
Medicinal ingredients
- MICONAZOLE NITRATE 23 MG per ML
- PREDNISOLONE ACETATE 5 MG per ML
- POLYMYXIN B SULFATE 0.5293 MG per ML